Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Blood|May 15, 1995
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factorR Stauder, W Eisterer, J Thaler, et al.British Journal of Haematology|November 1, 1995
Decreased potency of MDR-modulators under serum conditions determined by a functional assayC Ludescher, W Eisterer, W Hilbe, et al.Leukemia Research|September 1, 1994
Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16)W Hilbe, J Thaler, W Eisterer, et al.Clinical and Experimental Rheumatology|May 1, 1997
Oxidative burst of neutrophils in patients with rheumatoid arthritis: influence of various cytokines and medicationE Mur, A Zabernigg, W Hilbe, et al.Leukemia|February 1, 1995
Identification of a favorable subgroup of patients with generalized immunocytomas by follicular dendritic cellsW Eisterer, W Hilbe, F Fend, et al.Wiener Klinische Wochenschrift|January 1, 1994
[Functional detection of P-glycoprotein expressing cells with flow cytometry]C Ludescher, W Hilbe, W Eisterer, et al.Leukemia & Lymphoma|December 31, 1997
Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromesA Zabernigg, W Hilbe, W Eisterer, et al.Cancer Research|November 11, 1998
Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemiaO E Bechter, W Eisterer, G Pall, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 12, 2017
Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer : Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trialP Kogler, A F DeVries, W Eisterer, et al.Annals of the New York Academy of Sciences|July 19, 2001
Characterization of human hematopoietic cells with short-lived in vivo repopulating activityC Eaves, H Glimm, W Eisterer, et al.Pageof 4